全文获取类型
收费全文 | 1897篇 |
免费 | 151篇 |
国内免费 | 6篇 |
专业分类
耳鼻咽喉 | 15篇 |
儿科学 | 35篇 |
妇产科学 | 8篇 |
基础医学 | 163篇 |
口腔科学 | 40篇 |
临床医学 | 163篇 |
内科学 | 621篇 |
皮肤病学 | 109篇 |
神经病学 | 93篇 |
特种医学 | 42篇 |
外科学 | 215篇 |
综合类 | 11篇 |
预防医学 | 61篇 |
眼科学 | 140篇 |
药学 | 139篇 |
中国医学 | 2篇 |
肿瘤学 | 197篇 |
出版年
2023年 | 23篇 |
2022年 | 34篇 |
2021年 | 76篇 |
2020年 | 29篇 |
2019年 | 45篇 |
2018年 | 51篇 |
2017年 | 41篇 |
2016年 | 61篇 |
2015年 | 47篇 |
2014年 | 72篇 |
2013年 | 59篇 |
2012年 | 109篇 |
2011年 | 100篇 |
2010年 | 57篇 |
2009年 | 47篇 |
2008年 | 86篇 |
2007年 | 95篇 |
2006年 | 88篇 |
2005年 | 73篇 |
2004年 | 65篇 |
2003年 | 77篇 |
2002年 | 69篇 |
2001年 | 57篇 |
2000年 | 52篇 |
1999年 | 51篇 |
1998年 | 25篇 |
1997年 | 19篇 |
1996年 | 11篇 |
1995年 | 8篇 |
1994年 | 13篇 |
1993年 | 8篇 |
1992年 | 29篇 |
1991年 | 36篇 |
1990年 | 42篇 |
1989年 | 34篇 |
1988年 | 40篇 |
1987年 | 28篇 |
1986年 | 23篇 |
1985年 | 18篇 |
1984年 | 14篇 |
1983年 | 13篇 |
1982年 | 16篇 |
1980年 | 7篇 |
1979年 | 15篇 |
1975年 | 9篇 |
1974年 | 9篇 |
1973年 | 8篇 |
1972年 | 9篇 |
1971年 | 7篇 |
1966年 | 8篇 |
排序方式: 共有2054条查询结果,搜索用时 15 毫秒
21.
Y Naoe M Inami S Matsumoto S Takagaki T Fujiwara S Yamazaki I Kawamura F Nishigaki S Tsujimoto T Manda K Shimomura 《Japanese journal of cancer research》1998,89(12):1306-1317
The antitumor effects of FK317, a novel substituted dihydrobenzoxazine, were evaluated using human tumor xenografts (small cell lung cancer, non-small cell lung cancer, stomach cancer, colon cancer, pancreatic cancer, breast cancer, cervical cancer and ovarian cancer). Tumor growth-inhibitory effects and the effective dose-range of FK317 were much stronger and broader, respectively, than those of reference drugs such as mitomycin C, adriamycin, cisplatin, taxol and irinotecan. Furthermore, the body weight decrease and myelosuppression in FK317-treated mice were less than in the animals given any of the reference drugs. To explain this tumor selectivity, the distribution of FK317 was investigated after dosing tumor-bearing mice with the 14C-labelled compound. The concentration of FK317 in tumor tissues was relatively low, and long tumor retention was not observed. However, thin-layer chromatographic separation revealed that the radioactivity in the tumor resided mainly in strongly cytotoxic metabolites, while that in other tissues resided mainly in non-cytotoxic metabolites. These results suggest that FK317 shows strong antitumor activity without side effects, and one reason for this is its specific metabolite pattern. FK317 is now undergoing phase I clinical trials. 相似文献
22.
Y Naoe I Kawamura M Inami S Matsumoto F Nishigaki S Tsujimoto T Manda K Shimomura 《Japanese journal of cancer research》1998,89(12):1318-1325
The effects of FK317 (11-acetyl-8-carbamoyloxymethyl-4-formyl-6- methoxy-14-oxa-1,11-diazatetracyclo[7.4.1.0(2, 7). 0(10, 2] tetradeca-2,4,6-trien-9-yl acetate), a novel anti-cancer agent, on murine adenocarcinoma colon26- and human lung carcinoma LX-1-induced cachexia were investigated in mice. Mice bearing colon26 or LX-1 s.c. lost weight and became cachectic, associated with tumor growth. FK317 and mitomycin C (MMC) inhibited the growth of both tumors. FK317 ameliorated the weight loss induced by the presence of colon26 or LX-1, while MMC enhanced it. An attenuation of the reduction in the weights of epididymal fat, gastrocnemius muscle and carcass was observed in FK317-treated tumor-bearing mice in both cachexia models, but not in MMC-treated mice. The decreases in the circulating levels of triglyceride, glucose and non-esterified fatty acid, which were induced by the presence of colon26, was partially inhibited by treatment with FK317. Overall, this study revealed that FK317 is a potent anti-cancer drug with anti-cachectic activity, suggesting that FK317 has potential utility for the treatment of cancer. 相似文献
23.
Yoshinori Naoe Masamichi Inami Ikuo Kawamura Fusako Nishigaki Susumu Tsujimoto Sanae Matsumoto Toshitaka Manda Kyoichi Shimomura 《Cancer science》1998,89(6):666-672
FK317 is a member of a new class of bioreductive agents that exhibit strong cytotoxicity against various human cancer cells. The effect of FK317 was found to be stronger than that of mitomycin C (MMC), adriamycin (ADR) or cisplatin (CDDP). Alkaline elution analysis indicated that FK317 formed interstrand DNA-DNA and DNA-protein cross-links in cells. On the other hand, no DNA single-strand breaks were observed in the cells treated with FK317. In a cell-free system the deacetylated metabolites produced cross-linked DNA under reductive conditions, though FK317 itself did not form DNA-DNA cross-links. In order to elucidate the metabolic activation mechanisms, we established an FK317-resistant subline from human non-small cell lung cancer cells (Lu99) by stepwise and brief exposure (1 h) to FK317. The resistant subline (Lu99/317) showed cross-resistance to MMC and carboquone (CQ), but not to ADR or CDDP. DT-diaphorase, which is one of the activation enzymes of MMC and CQ, was deficient in Lu99/317 cells as determined by enzyme activity assay. However, the levels of NADPH:cytochrome P450 reductase, which is another activation enzyme for MMC and CQ, were comparable in resistant and parent cell lines. Treatment of the cells with dicumarol, an inhibitor of DT-diaphorase, reduced the cytotoxicity of FK317 to Lu99 cells, but not to Lu99/317 cells. These results indicate that deacetylation of FK317 is necessary for its reductive activation, and deacetylated FK317 is reduced by DT-diaphorase to form an active metabolite, which produces DNA-DNA interstrand and DNA-protein cross-links that lead to cell death. 相似文献
24.
25.
26.
A safe and reliable technique for fascial closure without special devices after laparoscopic surgery
27.
Waardenburg syndrome type IIE in a Japanese patient caused by a novel non‐frame‐shift duplication mutation in the SOX10 gene
下载免费PDF全文
![点击此处可从《The Journal of dermatology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
28.
Toshiaki Kogame Teruki Dainichi Yutaka Shimomura Miki Tanioka Kenji Kabashima Yoshiki Miyachi 《The Journal of dermatology》2014,41(12):1095-1097
Gap junction proteins are composed of 21 genes of the connexin (Cx) family. They play important roles in cell–cell contact by exchange of small molecules through hemichannels. Hence, mutations of Cx family genes affect various tissues of a body. The mutation of the GJA1 gene, which codes Cx43, causes oculodentodigital dysplasia (ODDD), commonly in an autosomal dominant manner with phenotypic variability. It has been believed that gene mutations causing truncation of the Cx43 C‐terminus is necessary and sufficient for palmoplantar keratosis (PPK) development in ODDD patients. Here, we report a case of an ODDD patient developing PPK with a GJA1 gene mutation (c.412G>A/p.Gly138Ser), which was previously reported in a case of ODDD without PPK and expected not to result in C‐terminal truncation of Cx43. This case suggests not only C‐terminal truncation, but also that a point mutation in the cytoplasmic region of Cx43 can cause PPK in ODDD patients. 相似文献
29.
30.